Cargando…
AKF-PD alleviates diabetic nephropathy via blocking the RAGE/AGEs/NOX and PKC/NOX Pathways
Diabetic nephropathy (DN) is a major complication of diabetes. Currently, drugs are not available to effectively control the disease. Fluorofenidone (AKF-PD) is a recently developed drug; it possesses activities in reducing DN progression in preclinical research. Nonetheless, its renal protection an...
Autores principales: | Qin, Jiao, Peng, Zhangzhe, Yuan, QiongJing, Li, Qian, Peng, Yu, Wen, Rui, Hu, Zhaolan, Liu, Jun, Xia, Xiongfang, Deng, Hong, Xiong, Xuan, Hu, Jinyue, Tao, Lijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416244/ https://www.ncbi.nlm.nih.gov/pubmed/30867431 http://dx.doi.org/10.1038/s41598-018-36344-w |
Ejemplares similares
-
Nox‐4 deletion reduces oxidative stress and injury by PKC‐α‐associated mechanisms in diabetic nephropathy
por: Thallas‐Bonke, Vicki, et al.
Publicado: (2014) -
Nox
por: Hettche, Thomas, 1964-
Publicado: (1996) -
Reduced Apoptotic Injury by Phenothiazine in Ischemic Stroke through the NOX-Akt/PKC Pathway
por: Tong, Yanna, et al.
Publicado: (2019) -
AGE/RAGE-Induced EMP Release via the NOX-Derived ROS Pathway
por: Chen, Ying-Hua, et al.
Publicado: (2018) -
Research on AR-AKF Model Denoising of the EMG Signal
por: Chen, Sijia, et al.
Publicado: (2021)